EMERGENCIAS
EMERGENCIAS
Hospital Juan Ramón Jiménez
Huelva, EspañaPublicaciones en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (9)
2021
-
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
Scientific Reports, Vol. 11, Núm. 1
2018
-
Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice (Clinical and Translational Oncology, (2018), 20, 7, (862-869), 10.1007/s12094-017-1797-9)
Clinical and Translational Oncology
-
Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
Clinical and Translational Oncology, Vol. 20, Núm. 7, pp. 862-869
2014
-
Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 160-166
2012
-
Premenstrual asthma and female sex hormones
Journal of Investigational Allergology and Clinical Immunology, Vol. 22, Núm. 6, pp. 437-439
-
Premenstrual asthma and leukotriene variations in the menstrual cycle
Allergologia et Immunopathologia, Vol. 40, Núm. 6, pp. 368-373
2010
-
Premenstrual asthma and atopy markers
Annals of Allergy, Asthma and Immunology, Vol. 105, Núm. 3, pp. 218-222
-
Premenstrual asthma and symptoms related to premenstrual syndrome
Journal of Asthma, Vol. 47, Núm. 8, pp. 835-840
-
Variability in the prevalence of premenstrual asthma
European Respiratory Journal, Vol. 35, Núm. 5, pp. 980-986